Thermoresponsive M1 macrophage-derived hybrid nanovesicles for improved in vivo tumor targeting.
Barone A, Zimbo AM, d'Avanzo N, Tolomeo AM, Ruga S, Cardamone A, Celia C, Scalise M, Torella D, La Deda M, Iaccino E, Paolino D.
Barone A, et al.
Drug Deliv Transl Res. 2023 Dec;13(12):3154-3168. doi: 10.1007/s13346-023-01378-9. Epub 2023 Jun 26.
Drug Deliv Transl Res. 2023.
PMID: 37365403
Free PMC article.